Chemical and biological agents for the control of molluscs
US-9259446-B2 · Feb 16, 2016 · US
Trans-2-decenoic acid derivative and drug containing same
US9428477B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9428477-B2 |
| Application number | US-201314395241-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 26, 2013 |
| Priority date | Apr 27, 2012 |
| Publication date | Aug 30, 2016 |
| Grant date | Aug 30, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a novel trans-2-decenoic acid derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical agent containing the compound as an active ingredient. The trans-2-decenoic acid derivative or a pharmaceutically acceptable salt, which is the compound of the present invention, is specifically represented by the general formula (I): wherein X is a substituent such as a 1-pyrrolidyl, a 3-thiazolizyl, or a piperidino, and the compound is highly useful as a pharmaceutical agent, such as a prophylactic or therapeutic agent for a peripheral nerve disorder induced by administration of an anticancer agent, a prophylactic or therapeutic agent for neurodegenerative diseases or mental diseases such as dementia, Alzheimer's disease, Parkinson's disease, diabetic neuropathy, depression, glaucoma, or autistic disorder spectrum, a therapeutic or repairing agent for spinal cord injury, analgesics against various pain diseases, or the like.
First claim
Opening claim text (preview).
The invention claimed is: 1. A trans-2-decenoic acid derivative represented by the following general formula (I′) or a pharmaceutically acceptable salt thereof: wherein X′ is: (a) a 1-pyrrolidyl substituted with carboxyl or alkoxycarbonyl, (b) a 3-thiazolidyl, (c) a piperidino substituted with oxo, hydroxy, alkoxy, carboxyl, alkoxycarbonyl, alkylam…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9428477B2 cover?
- The present invention relates to a novel trans-2-decenoic acid derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical agent containing the compound as an active ingredient. The trans-2-decenoic acid derivative or a pharmaceutically acceptable salt, which is the compound of the present invention, is specifically represented by the general formula (I): …
- Who is the assignee on this patent?
- Nippon Zoki Pharmaceutical Co, Nagoya Ind Science Res Inst
- What technology area does this patent fall under?
- Primary CPC classification C07D295/185. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).